Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Titan Biotech Announces 1:4 Bonus Share Issue and Rs 0.50 Dividend for FY26

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Titan Biotech Announces 1:4 Bonus Share Issue and Rs 0.50 Dividend for FY26

Analysed 3 Sept 2026·3 sources analysed·India·Business
Titan Biotech Announces 1:4 Bonus Share Issue and Rs 0.50 Dividend for FY26PreviousNext

Titan Biotech announced a 1:4 bonus share issue, granting one new share for every four held, subject to shareholder approval. The company also declared a final dividend of Rs 0.50 per share for FY26, with September 22 set as the record date. Titan Biotech, which produces biological products for various industries, has seen strong stock gains over the past year. The bonus issue aims to increase share capital and potentially improve liquidity, pending necessary approvals and shareholder consent.

Sentiment
66%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (66/100). Lens Score 36/100.

Outlets measured: businessstandard, businessstandard, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 3 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (66/100)

Sentiment was consistent across outlets (55–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 3 Sept, 07:53 am. Other outlets followed.

3 Sept, 07:53 am3 sources · 2 h3 Sept, 09:52 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Business Nextgen Finance Raises Rs 215 Crore Equity to Expand MSME Lending
Next →
Studies Explore Coconut Shells and Sugarcane Ash as Sustainable Concrete Materials
  1. 1
    economictimes3 Sept, 07:53 am
    Bonus issue alert! Multibagger Titan Biotech announces its maiden 1:4 bonus issue
  2. 2
    businessstandard3 Sept, 09:45 am
    Titan Biotech jumps 5 on 1:4 bonus issue, dividend announcements
  3. 3
    businessstandard3 Sept, 09:52 am
    Titan Biotech spurts after board approves 1:4 bonus issue

Who's involved

Institutions and figures named across source coverage.

Corporate
Globe Capital MarketTitan BiotechTitan Biotech Limited

Story context

Category
Business
Location
India
Sources analysed
3
Last analysed
3 Sept 2026
Key entities
Titan (moon)Indian rupeeDividendShare priceCollagenNutritionEquity (finance)Market capitalizationMarket liquidityShareholderCroreHDFC Bank